Basal ganglia vulnerability to oxidative stress

Frontiers in Neuroscience

Volumn , Issue 8 APR, 2014, Pages

  Jensen, Nina ^a   Oliveira, João R M ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

DHA; Essential fatty acids; Neurodegeneration; Oxidative stress; Resilience

Indexed keywords

DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ESSENTIAL FATTY ACID; ICOSANOID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID;

ALZHEIMER DISEASE; BASAL GANGLION; BRAIN CORTEX; BRAIN DEATH; BRAIN FUNCTION; CAUDATE NUCLEUS; CEREBELLUM; CORPUS STRIATUM; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; FOLLOW UP; HUMAN; LIPID PEROXIDATION; MEMBRANE FLUIDITY; MESENCEPHALON; NERVE CELL MEMBRANE; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NOTE; OXIDATIVE STRESS; PARKINSON DISEASE; PUTAMEN; SUBSTANTIA NIGRA;

EID: 84904994179     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2014.00080     Document Type: Note

References (18)

1. Cardoso, H. D., Passos, P. P., Lagranha, C. J., Ferraz, A. C., Santos Júnior, E. F., Oliveira, R. S., et al. (2012). Differential vulnerability of substantia nigra and corpus striatum to oxidative insult induced by reduced dietary levels of essential fatty acids. Front. Hum. Neurosci. 6:249. doi: 10.3389/fnhum.2012.00249.
2. Cardoso, H. D., Santos Júnior, E. F., Santana, D. F., Gonçalves-Pimentel, C., Angelima, M. K., Isaac, A. R., et al. (2013). Omega-3 deficiency and neurodegeneration in the substantia nigra: involvement of increased nitric oxide production and reduced BDNF expression. Biochim. Biophys. Acta 1840, 1902-1912. doi: 10.1016/j.bbagen.2013.12.023.
3. Eldho, N. V., Feller, S. E., Tristram-Nagle, S., Polozov, I. V., and Gawrisch, K. (2003). Polyunsaturated docosahexaenoic vs docosapentaenoic acid-differences in lipid matrix properties from the loss of one double bond. J. Am. Chem. Soc. 125, 6409-6421. doi: 10.1021/ja029029o.
4. Ernst, A., Alkass, K., Bernard, S., Salehpour, M., Perl, S., Tisdale, J., et al. (2014). Neurogenesis in the striatum of the adult human brain. Cell 156, 1072-1083. doi: 10.1016/j.cell.2014.01.044.
5. Jansen, C., and Kliaan, A. (2014). Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration. Prog. Lipid Res. 53, 1-17. doi: 10.1016/j.plipres.2013.10.002.
6. Kidd, P. M. (2000). Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management. Altern. Med. Rev. 5, 502-545..
7. Kiecolt-Glaser, J. K., Epel, E. S., Belury, M. A., Andridge, R., Line, J., Glaser, R., et al. (2013). Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: a randomized controlled trial. Brain Behav. Immun. 28, 16-24. doi: 10.1016/j.bbi.2012.09.004.
8. Luchtman, D. W., and Song, C. (2013). Cognitive enhancement by omega-3 fatty acids from child-hood to old age: findings from animal and clinical studies. Neuropharmacology 64, 550-565. doi: 10.1016/j.neuropharm.2012.07.019.
9. Malcolm, P., Murphu, B., Shay, J., and Horribin, D. (1998). Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol. Psychiatry 43, 315-319. doi: 10.1016/S0006-3223(97)00206-0.
10. Melo, A., Monteiro, L., Lima, R. M., Oliveira, D. M., Cergueira, M. D., and El-Bachá, R. S. (2011). Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives. Oxid. Med. Cell. Longev 2011:467180. doi: 10.1155/2011/467180.
11. Navarro, A., and Boveris, A. (2009). Brain mitochondrial dysfunction and oxidative damage in Parkinson's disease. J. Bioenerg. Biomembr. 41, 517-521. doi: 10.1007/s10863-009-9250-6.
12. Passos, P. P., Borba, J. M. C., Rocha-de-Melo, A. P., Guedes, R. C. A., Silva, R. P., Melo Filho, W. T., et al. (2012). Dopaminergic cell populations of the rat substantia nigra are differentially affected by essential fatty acid dietary restriction over two generations. J. Chem. Neuroanat. 44, 66-75. doi: 10.1016/j.jchemneu.2012.05.003.
13. Radak, Z., Zhao, Z., Goto, S., and Koltai, E. (2011). Age-associated neurodegeneration and oxidative damage to lipids, proteins and DNA. Mol. Aspects Med. 32, 305-315. doi: 10.1016/j.bbi.2012.09.004.
14. Schmitz, G., and Ecker, J. (2008). The opposing effects of n-3 and n- 6 fatty acids. Prog. Lipid Res. 47, 147-155. doi: 10.1016/j.plipres.2007.12.004.
15. Sultana, R., Perluigi, M., and Butterfield, D. A. (2013). Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain. Free Radic. Biol. Med. 62, 157-169. doi: 10.1016/j.freeradbiomed.2012.09.027.
16. Tong, J., Furukawa, Y., Sherwin, A., Hornykiewicz, O., and Kish, S. J. (2011). Heterogeneous intrastriatal pattern of proteins regulating axon growth in normal adult human brain. Neurobiol. Dis. 41, 458-468. doi: 10.1016/j.nbd.2010.10.017.
17. Yavin, E., Brand, A., and Green, P. (2002). Docosahexaenoic acid abundance in the brain: a biodevice to combat oxidative stress. Nutr. Neurosci. 5, 149-157. doi: 10.1080/10284150290003159.
18. Yehuda, S., Rabinovitz, S., Carasso, R. L., and Mostofsky, D. I. (2002). The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol. Aging 23, 843-853. doi: 10.1016/S0197-4580(02)00074-X